Adenine arabinoside therapy in corneal stromal disease and iritis due to herpes simplex.
D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000368:Aged; D000867:Anterior Chamber / Q000601:surgery; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001082:Aqueous Humor / Q000032:analysis; D001089:Arabinose / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006561:Herpes Simplex; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D007429:Intraocular Pressure / Q000187:drug effects; D007500:Iritis / Q000188:drug therapy / Q000209:etiology*; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D011677:Punctures; D010948:Viral Plaque Assay; D014792:Visual Acuity / Q000187:drug effects
D000998:Antiviral Agents; D009705:Nucleosides; D009883:Ophthalmic Solutions; D001089:Arabinose; D000225:Adenine